Source: School Course 13



Rating:

Share or cite this content

Citations should be made in the following way:
M. Dara (Geneva, Switzerland). New guidelines to manage MDR-TB. School Course 13

Member's Comments

No comment yet.

Related content which might interest you: New perspectives in MDR-TB management Source: International Congress 2016 – China Session II Year: 2016 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Are TB services in England adhering to new NICE guidelines on screening for latent TB? Source: International Congress 2017 – Migrants and screening Year: 2017 Management of drug resistant pulmonary TB. New problems and perspectives Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 New and repurposed drugs for MDR-TB patients Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence  Year: 2017 New methodologogic approaches to the management of antituberculous service Source: Eur Respir J 2003; 22: Suppl. 45, 381s Year: 2003 ECDC guidance on management of contacts of MDR-TB and XDR-TB patients Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Developing standards for TB and MDR-TB management in the European Union setting Source: Annual Congress 2010 - Multidrug-resistant tuberculosis and novel influenza: back to the future - "Lessons learnt from two respiratory emergencies" Year: 2010 The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice Year: 2019 New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002 New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Out-patient MDR-TB care in Moldova Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Failure predictors when treating MDR-TB Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015